期刊文献+

双歧三联活菌联合西替利嗪治疗小儿湿疹及对其免疫球蛋白水平的影响 被引量:1

Effect of Bifid Triple Viable Combined with Cetirizine on Immunoglobulin Levels in Children with Atopic Dermatitis
下载PDF
导出
摘要 目的研究双歧三联活菌联合西替利嗪治疗小儿湿疹(AD)对其免疫球蛋白水平的影响。方法选取2020年4月-2021年4月佳木斯市中心医院儿科接诊的78例AD患儿,采用随机数字表法分为对照组与观察组,各39例。对照组给予西替利嗪治疗,观察组在其基础上联合双歧三联活菌治疗,比较两组临床疗效、肠道菌群数量、炎性因子及免疫球蛋白水平。结果观察组治疗有效率为87.18%,高于对照组的71.79%,差异有统计学意义(P<0.05);观察组双歧杆菌及乳杆菌数量高于治疗前,大肠埃希菌数量低于治疗前,差异有统计学意义(P<0.05);两组IL-4、IL-10、IgG、IgM均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。结论双歧三联活菌联合西替利嗪治疗AD疗效确切,可改善患儿肠道菌群,减轻机体炎性反应,提高其免疫功能。 Objective To study the effect of bifid triple viable combined with cetirizine on immunoglobulin levels in children with atopic dermatitis(AD).Methods A total of 78 children with AD admitted to Jiamusi Central Hospital from April 2020 to April 2021 were selected and randomly divided into control group and observation group,with 39 cases in each group.The control group was treated with cetirizine,and the observation group was treated with bifid triple viable bacteria on the basis of cetirizine.The clinical efficacy,intestinal flora,inflammatory factors and immunoglobulin levels were compared between the two groups.Results The effective rate of the observation group was 87.18%,which was higher than 71.79%of the control group,and the difference was statistically significant(P<0.05).The number of Bifidobacterium and Lactobacillus in the observation group was higher than that before treatment,and the number of Escherichia coli was lower than that before treatment,the difference was statistically significant(P<0.05).The levels of IL-4,IL-10,IgG and IgM in the two groups were lower than those before treatment,and those in the observation group were lower than those in the control group,with significant difference(P<0.05).Conclusion The combination of bifidus triple viable bacteria combined with cetirizine has a definite effect in the treatment of AD,which can improve the intestinal flora of children,reduce the body's inflammatory response,and improve their immune function.
作者 张舒扬 ZHANG Shu-yang(Department of Pediatrics,Jiamusi Central Hospital,Jiamusi 154000,Heilongjiang,China)
出处 《医学信息》 2022年第3期159-161,共3页 Journal of Medical Information
关键词 小儿湿疹 双歧三联活菌 西替利嗪 免疫球蛋白 炎性因子 Atopic dermatitis Bifid triple viable bacteria Cetirizine Immunoglobulin Inflammatory factors
  • 相关文献

参考文献13

二级参考文献87

  • 1王爱宇.益生菌的研究进展及在儿科的临床应用[J].安徽医药,2007,11(2):169-170. 被引量:13
  • 2Leung DY, Bieber T.Atopic dermatitis [J].Lancet, 2003, 361 (9352) : 151-160.
  • 3Akdis CA, Akdis M, Bieber T, et al.Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report [J ].Allergy, 2006,61 (8):969-987.
  • 4Furue M, Saeki H, Furukawa F, et al.Guidelines for management of atopic dermatitis [ J ].Jpn J Dermatol, 2008,118 : 325-342.
  • 5Norito KATOH.Future perspectives in the treatment of atopie dermatitis [J ].J Dermatol, 2009,36 : 367-376.
  • 6Peserico A, Stadtler G, Sebastian M, et al.Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study[J ].Br J Dermatol, 2008,158 : 801-807.
  • 7Peeters KABM, Mascini EM, Sanders CJG. Resistance of Staphylococcus aureus to fusidic acid [J].Int J Dermatol, 2004,43: 235-237.
  • 8Hoeger PH.Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis [ J ] .Pediatr Allergy Immunol, 2004,15:474-477.
  • 9Akhavan A, Rudikoff D.The treatment of atopic dermatitis with systemic immunosnppressive agents [J].Clin Dermatol, 2003, 21 : 225-240.
  • 10Magomhedze G,Reddy PB,Eda S,et al. Cellular and pop- ulation plasticity of helper CD4+ T cell responses ]-J]. Frontiers Physiology, 2013 (4) : 206.

共引文献101

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部